Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 285

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

Pratcorona, Marta, Brunet, Salut, Nomdedéu, Josep, Ribera, Josep Maria, Tormo, Mar, Duarte, Rafael, Escoda, Lourdes, Guàrdia, Ramon, Queipo de Llano, M. Paz, Salamero, Olga, Bargay, Joan, Pedro, Carmen, Martí, Josep Maria, Torrebadell, Montserrat, Díaz-Beyá, Marina, Camós, Mireia, Colomer, Dolors, Hoyos, Montserrat, Sierra, Jorge, Esteve, Jordi · 2013 · Blood

Abstract

Key Points: In intermediate-risk AML, effect of FLT3 burden is modulated by NPM1 mutation, especially in patients with a low ratio. Combined evaluation of NPM1 mutation and FLT3-ITD burden might contribute to identify patients who benefit from early allogeneic HSCT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2012-06-431122

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 285

Metadata

Authors
Pratcorona, M., Brunet, S., Nomdedéu, J., Ribera, J. M., Tormo, M., Duarte, R., Escoda, L., Guàrdia, R., Queipo de Llano, M. P., Salamero, O., Bargay, J., Pedro, C., Martí, J. M., Torrebadell, M., Díaz-Beyá, M., Camós, M., Colomer, D., Hoyos, M., Sierra, J., & Esteve, J.
Venue
Blood
Published
2013-04-04
Volume
121
Issue
14
Pages
2734-2738
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2052886921
Cited by
285
References
23
FWCI
14.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy. https://app.cochat.ai/papers/10.1182/blood-2012-06-431122
The paper
Pratcorona, M., Brunet, S., Nomdedéu, J., Ribera, J. M., Tormo, M., Duarte, R., Escoda, L., Guàrdia, R., Queipo de Llano, M. P., Salamero, O., Bargay, J., Pedro, C., Martí, J. M., Torrebadell, M., Díaz-Beyá, M., Camós, M., Colomer, D., Hoyos, M., Sierra, J., & Esteve, J. (2013). Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy. Blood. https://doi.org/10.1182/blood-2012-06-431122

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.